The Breast Surgery Research Group of the Department of Surgery at McMaster University’s Faculty of Health Sciences has received funding from the BRIGHT Run to investigate a way to reduce the incidence of seroma and hematoma among patients who have had breast cancer...
Bright Run funded projects
Identifying Tumour Margins
Breast cancer is the second leading cause of cancer death among women. There is a need to optimize the speed and accuracy of diagnosis and maximize efficiency in treatment of the disease. This proposal will contribute to the efficiency of breast cancer surgery and...
Thyroid Hormone Receptors
The survival of breast cancer patients has improved in the past 20 years due to advancements in systemic therapy e.g. endocrine therapy, chemotherapy, and anti-HER2 directed therapy. These therapies benefit patients whose cancers display hormone receptors called...
Stereotactic Body Radiotherapy
Stereotactic body radiotherapy (SBRT) refers to a type of radiation therapy which delivers high doses of radiation focused precisely-targeted on the tumor, thereby sparing adjacent normal tissues and limiting side effects. It can deliver radiation in a shorter...
Young Women with Breast Cancer
This study aimed to gather and analyze the physical, psycho-social and informational needs of young women with breast cancer (YWBC) at the Juravinski Regional Cancer Centre. Participants attended either a focus group or interview that was moderated by following a...
Identification of a Triple Negative Breast Cancer
Triple negative (TN) breast cancer (estrogen receptor negative, progesterone receptor negative, and Her2 neu not overexpressed) is often more aggressive than other forms of breast cancer. It is also more common in women of African Ancestry (WAA). Our lab has been...